Commonwealth Equity Services’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,930
| Closed | -$281K | – | 4105 |
|
|
2024
Q1 | $281K | Buy |
7,930
+99
| +1% | +$3.51K | ﹤0.01% | 3330 |
|
|
2023
Q4 | $341K | Buy |
7,831
+153
| +2% | +$6.66K | ﹤0.01% | 3062 |
|
|
2023
Q3 | $293K | Buy |
7,678
+3
| +0% | +$114 | ﹤0.01% | 3052 |
|
|
2023
Q2 | $316K | Sell |
7,675
-241
| -3% | -$9.92K | ﹤0.01% | 3010 |
|
|
2023
Q1 | $454 | Buy |
7,916
+263
| +3% | +$15 | ﹤0.01% | 2642 |
|
|
2022
Q4 | $429K | Sell |
7,653
-1,275
| -14% | -$71.5K | ﹤0.01% | 2592 |
|
|
2022
Q3 | $378K | Sell |
8,928
-470
| -5% | -$19.9K | ﹤0.01% | 2631 |
|
|
2022
Q2 | $507K | Sell |
9,398
-829
| -8% | -$44.7K | ﹤0.01% | 2388 |
|
|
2022
Q1 | $657K | Sell |
10,227
-163
| -2% | -$10.5K | ﹤0.01% | 2310 |
|
|
2021
Q4 | $696K | Buy |
10,390
+419
| +4% | +$28.1K | ﹤0.01% | 2257 |
|
|
2021
Q3 | $682K | Buy |
9,971
+150
| +2% | +$10.3K | ﹤0.01% | 2235 |
|
|
2021
Q2 | $670K | Buy |
9,821
+2,845
| +41% | +$194K | ﹤0.01% | 2229 |
|
|
2021
Q1 | $481K | Buy |
6,976
+131
| +2% | +$9.03K | ﹤0.01% | 2360 |
|
|
2020
Q4 | $444K | Sell |
6,845
-831
| -11% | -$53.9K | ﹤0.01% | 2231 |
|
|
2020
Q3 | $362K | Buy |
7,676
+845
| +12% | +$39.9K | ﹤0.01% | 2219 |
|
|
2020
Q2 | $320K | Sell |
6,831
-4,061
| -37% | -$190K | ﹤0.01% | 2235 |
|
|
2020
Q1 | $486K | Sell |
10,892
-725
| -6% | -$32.3K | ﹤0.01% | 1714 |
|
|
2019
Q4 | $677K | Buy |
11,617
+36
| +0.3% | +$2.1K | ﹤0.01% | 1676 |
|
|
2019
Q3 | $695K | Sell |
11,581
-150
| -1% | -$9K | ﹤0.01% | 1591 |
|
|
2019
Q2 | $655K | Sell |
11,731
-139
| -1% | -$7.76K | ﹤0.01% | 1612 |
|
|
2019
Q1 | $661K | Sell |
11,870
-133
| -1% | -$7.41K | ﹤0.01% | 1564 |
|
|
2018
Q4 | $541K | Buy |
12,003
+90
| +0.8% | +$4.06K | ﹤0.01% | 1590 |
|
|
2018
Q3 | $784K | Buy |
11,913
+965
| +9% | +$63.5K | ﹤0.01% | 1467 |
|
|
2018
Q2 | $705K | Buy |
10,948
+489
| +5% | +$31.5K | ﹤0.01% | 1505 |
|
|
2018
Q1 | $578K | Buy |
10,459
+265
| +3% | +$14.6K | ﹤0.01% | 1621 |
|
|
2017
Q4 | $488K | Buy |
10,194
+824
| +9% | +$39.4K | ﹤0.01% | 1718 |
|
|
2017
Q3 | $473K | Buy |
9,370
+545
| +6% | +$27.5K | ﹤0.01% | 1651 |
|
|
2017
Q2 | $481K | Buy |
8,825
+2,778
| +46% | +$151K | ﹤0.01% | 1596 |
|
|
2017
Q1 | $255K | Buy |
6,047
+887
| +17% | +$37.4K | ﹤0.01% | 1975 |
|
|
2016
Q4 | $221K | Buy |
+5,160
| New | +$221K | ﹤0.01% | 1985 |
|